Use of Immunosuppressants/Immunomodulators in Autoimmune/Inflammatory Dermatologic Diseases during COVID-19 Pandemic-General Recommendation Based on Available Evidence.

ABSTRACT:

SUBMITTER: De D 

PROVIDER: S-EPMC7413441 | biostudies-literature | 2020 Jul-Aug

REPOSITORIES: biostudies-literature